H5N1 AI is a highly pathogenic avian influenza virus that is easily transmitted between birds and is a zoonotic disease (a disease that transmits from animals to people), but it is not well adapted to mammals. There have been reports of possible limited human-to-human transmission, but there has been no evidence of ongoing transmission between people.
This moderated, live webinar discusses the National Advisory Committee on Immunization (NACI) recommendations on seasonal influenza vaccine use for the 2022-2023 season. The webinar addresses the role of health care providers in vaccine uptake and will include an overview of antiviral treatment of influenza. The presentations are followed by a question and answer period.
Learn about this year’s recommendations for the prevention and treatment of seasonal influenza, the use of antivirals, the recommended vaccinations, and infection and prevention control measures to reduce the risk of COVID-19 transmission at the time of flu vaccine administration.
Influenza constantly evolves. Learn about the 2019-2020 recommendations for prevention and treatment of seasonal influenza. Speakers:Dr. Ian Gemmill and Dr. Gerald Evans, Infectious disease experts Speakers presented the recommendations from the National Advisory Committee on Immunization’s(NACI) Seasonal Influenza Vaccine Statement 2019-2020, and the Association of Medical Microbiology andInfectious Disease (AMMI) Canada’s Guidance for Practitioners on…
Summary of the National Advisory Committee on Immunization’s Seasonal Influenza Statement and the Association of Medical Microbiology and Infectious Disease Canada’s Treatment Recommendations for frontline healthcare practitioners and public health vaccine providers to help guide their practice.
Dr. Ian Gemmill presented on prevention of seasonal influenza, types of vaccines available and their effectiveness, new indications and available internet resources. Dr. Gerald Evans presented on the burden of seasonal influenza, the trends in recent years and the antiviral treatment recommendations.
Dr. Richard Schabas MD, MHP, CCMF, FRCPCDr. Joel Kettner MD, MSc, FRCSC, FRCPC (Scientific Moderator) An archived version of this webinar is now available for viewing. Please email us to request access. The National Advisory Committee on Immunization recommends “influenza vaccination for all individuals aged six months and older” in Canada. But what is the evidence for universal programs?…
A systematic review of the literature to summarize the epidemiologic evidence on the effectiveness of seasonal influenza vaccines against A (H1N1) pdm09 infection in post-pandemic seasons.
According to Canada’s National Advisory Committee on Immunization (NACI), annual vaccination against influenza remains the best available strategy for reducing the risk of serious illness and death due to influenza. This systematic review summarizes epidemiologic evidence on the effectiveness of seasonal influenza vaccines against A (H1N1) pdm09 infection in post-pandemic seasons.
Influenza and influenza-like illnesses (ILI) are persistent public health problems due to seasonal influenza and other respiratory pathogens as well as emergency pandemic situations. There are many questions about surveillance methods, estimates of the burden of influenza, the effectiveness of vaccines and other prevention strategies, and equitable delivery of services.
ARCHIVED: INCLUDED FOR REFERENCE PURPOSES ONLY
